Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.86/Share
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.95) reported last year. Revenue for the quarter came in at $715 thousand, versus $205 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP shares slide as tech giant forecasts 2027 PC market slump
- Bernstein on Otis Worldwide Corp (OTIS) CEO transition: 'Investors we’ve spoken with have been largely cautious on the news'
- KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
